Ah Young Yoo

Ah Young Yoo

Auto-generated profile, based on publicly available information

Ah Young Yoo

Division of Gastroenterology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2023 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MJMoon Kyung Joo
Moon Kyung Joo
JPJong-Jae Park
Jong-Jae Park
YLYeon Ho Lee
Yeon Ho Lee
BLBeom Jae Lee
Beom Jae Lee
SKSeong Min Kim
Seong Min Kim
SLSang Woo Lee
Sang Woo Lee
Moon Kyung Joo, Jong-Jae Park, Yeon Ho Lee, Beom Jae Lee, Seong Min Kim, Won Shik Kim, Ah Young Yoo, Hoon Jai Chun, and Sang Woo Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl210454

30 January 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
AYAh Young Yoo
Ah Young Yoo
BLBeom Jae Lee
Beom Jae Lee
WKWon Shik Kim
Won Shik Kim
SKSeong Min Kim
Seong Min Kim
SKSeung Han Kim
Seung Han Kim
JPJong-Jae Park
Jong-Jae Park
Small bowel malignancies often present a diagnostic challenge due to their relative rarity and nonspecific clinical symptoms. However, technical developments in endoscopic instruments, including video capsule endoscopy (VCE) and enteroscopy, have allowed for the visualization of the entire small bowel. This study aimed to investigate the clinicopathological features of small bowel malignant tumors diagnosed by VCE and double-balloon enteroscopy (DBE) in a single tertiary center. We retrospectively analyzed VCE and DBE findings from Korea University Guro Hospital from January 2010 through September 2018. A total of 510 VCE and 126 DBE examinations were performed in 478 patients. Small bowel malignancies were diagnosed in 28 patients (15 males; mean age, 61.0 years; range, 42 to 81 years). Among them, 8 had lymphoma, 8 had primary adenocarcinoma, 7 had gastrointestinal stromal tumor (GIST) and 5 had metastatic cancer. Abdominal pain and obstructive symptoms were the most common findings in metastatic cancers (4/5, 80%). On the other hand, obscure gastrointestinal bleeding was the most common symptom of GIST (6/7, 85.7%) and adenocarcinoma (3/8, 37.5%). Approximately 6% of the patients who underwent either VCE or DBE were diagnosed with small bowel malignancy. These findings demonstrated the different clinical characteristics among small bowel malignancies and merit further study.

10 December 2019 in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Verified
Journal Article
Open access
PDF file
AYAh-Young Yoo
Ah-Young Yoo
JPJong-Jae Park
Jong-Jae Park
MJMoon Kyung Joo
Moon Kyung Joo
BLBeom Jae Lee
Beom Jae Lee
HCHoon Jai Chun
Hoon Jai Chun
SLSang Woo Lee
Sang Woo Lee
Background/Aims: Helicobacter pylori (H. pylori) eradication is known to be effective for reducing the size of gastric hyperplastic polyps (HPPs). This study investigated the change in size of gastric HPPs after H. pylori eradication. Materials and Methods: This was a prospective study that enrolled 25 H. pylori-positive patients diagnosed as having HPPs at Korea University Guro Hospital between July 2015 and July 2016. If the patient wanted to receive eradication therapy, medication was given. If the patients refused eradication, only clinical follow-up was performed. All patients were subsequently followed up with endoscopic examination to determine any change in polyp size. Results: Eighteen of the 25 H. pylori-positive patients diagnosed as having HPPs were given an eradication regimen, and 17 were confirmed to have achieved successful eradication. Twelve (70.8%) of the 17 patients in the eradication group showed ≥50% reduction in size, while two (25.0%) of the eight patients in the non-eradication group showed 50% reduction. The polyp regression rate was significantly higher in the eradication group (P=0.03). A multivariate analysis revealed that H. pylori eradication (OR, 40.047; 95% CI, 1.112~1442.767; P=0.044) and female sex (OR, 12.947; 95% CI, 1.038~161.503; P=0.047) were significant predictive factors of HPP regression. Conclusions: H. pylori eradication is an effective therapeutic modality for gastric HPP regression. (Korean J Helicobacter Up